Michel Weber

Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial

Arshad M. Khanani, Sunil Patel, Giovanni Staurenghi et al. · The Lancet · 2023 · 263 citations · Full text

Clinical Epidemiology, Clinical Trials, Geographic Atrophy +5

Restoration of vision in RPE65-deficient Briard dogs using an AAV serotype 4 vector that specifically targets the retinal pigmented epithelium

Guylène Le Meur, Knut Stieger, Alexander J. Smith et al. · Gene Therapy · 2006 · 200 citations

Biology, Rpe65-deficient Briard Dogs, Ocular Disease +10

Recombinant adeno-associated virus serotype 4 mediates unique and exclusive long-term transduction of retinal pigmented epithelium in rat, dog, and nonhuman primate after subretinal delivery

Michel Weber, Joseph E. Rabinowitz, Nathalie Provost et al. · Molecular Therapy · 2003 · 196 citations · Full text

ADJUVITE: a double-blind, randomised, placebo-controlled trial of adalimumab in early onset, chronic, juvenile idiopathic arthritis-associated anterior uveitis

Pierre Quartier, Amandine Baptiste, V. Despert et al. · Annals of the Rheumatic Diseases · 2017 · 163 citations

Sustained Delivery Fluocinolone Acetonide Vitreous Implants

José Cunha‐Vaz, Paul Ashton, Raymond Iezzi et al. · Ophthalmology · 2014 · 152 citations